Weekly Top Insider Buys: VTR, INCY, FULT, HMA, CMC
Ventas Inc. (VTR): Director Richard I Gilchrist Bought 2,500 Shares
Director of Ventas Inc., Richard I Gilchrist, bought 2,500 shares on 01/18/2012 at an average price of $56.42. Ventas Inc. is a healthcare real estate investment trust. Ventas Inc. has a market cap of $16.24 billion; its shares were traded at around $56.42 with a P/E ratio of 17.6 and P/S ratio of 16. The dividend yield of Ventas Inc. stocks is 4.1%. Ventas Inc. had an annual average earnings growth of 6.5% over the past 10 years.
On November 4, Ventas Inc. reported that normalized Funds From Operations (“FFO”) for the quarter ended September 30, 2011 increased approximately 120 percent to $255.1 million, from $115.4 million for the comparable 2010 period. Normalized FFO per diluted common share was $0.88 for the quarter ended September 30, 2011, an increase of 20.5 percent from $0.73 for the comparable 2010 period. Weighted average diluted shares outstanding in the third quarter of 2011 rose by 84.1 percent to 290.8 million, compared to 157.9 million in the comparable 2010 period
Last week, Director Richard I. Gilchrist bought 2,500 shares of VTR stock. This month, Prometheus Senior Quarters LLC, LFCM Holdings LLC, Director Matthew J. Lustig, and Director Douglas M. Pasquale sold shares.
Incyte Corp. (INCY): Director Paul A Brooke Bought 50,000 Shares
Director of Incyte Corp., Paul A Brooke, bought 50,000 shares on 1/19/2012 at an average price of $17.28. Incyte Corp is a drug discovery company that is using its expertise in genomics, medicinal chemistry and molecular, cellular and in vivo biology to discover and develop novel therapeutics. Incyte Corp. has a market cap of $2.18 billion; its shares were traded at around $17.28 with and P/S ratio of 12.9.
On October 27, Incyte Corp. reported results for the third quarter of 2011. Net loss for the quarter ended Sept. 30, 2011 was $53.1 million, or $0.42 per share, as compared to net loss of $31.7 million, or $0.26 per share, respectively, for the same period in 2010. Total revenues for the quarter ended Sept. 30, 2011 were $16.8 million as compared to $16.9 million for the same period in 2010.
This month, Director Paul A. Brooke, Director, 10% Owner C. Baker Brothers Life Sciences, and Director, 10% Owner Capital (gp) LLC 14159 shares of INCY stock.
Fulton Financial Corp. (FULT): Director Joe N Ballard Bought 2,000 Shares
Director of Fulton Financial Corp., Joe N. Ballard, bought 2,000 shares on 1/20/2012 at an average price of $9.49. Fulton Financial Corp. is a bank holding company. It provides retail and commercial banking and investment management and trust services in central and eastern Pennsylvania, southern New Jersey, northern Maryland and southern Delaware through its wholly-owned subsidiaries: Fulton Bank, Lebanon Valley Farmers Bank, Swineford National Bank, Lafayette Ambassador Bank, FNB Bank, N. Fulton Financial Corp. has a market cap of $1.9 billion; its shares were traded at around $9.49 with a P/E ratio of 13.3 and P/S ratio of 2. The dividend yield of Fulton Financial Corp. stocks is 2.6%.
On October 18, Fulton Financial Corporation reported results for the third quarter of 2011. Diluted earnings per share for the third quarter of 2011 was 20 cents, an 11.1 percent increase from the second quarter of 2011 and a 25.0 percent increase from the third quarter of 2010. The company reported net income of $39.3 million, or 20 cents per diluted share, for the third quarter ended Sept. 30, 2011, compared to $36.4 million, or 18 cents per diluted share, for the second quarter of 2011.
Last week, Director Joe N. Ballard bought 2,000 shares of FULT stock. Director Rufus A. Fulton Jr. bought 2,000 shares in September. Senior Executive Vice President Craig A. Roda bought 2,350 shares in August and Director Craig A. Dally sold 3,000 shares in October.
Health Management Associates Inc. (HMA): EVP of Operations Finance Kerrin E. Gillespie Bought 25,000 Shares
Executive Vice President of Operations Finance of Health Management Associates Inc. Kerrin E. Gillespie bought 25,000 shares on 01/19/2012 at an average price of $6.26. Health Management Associates Inc. provides a broad range of general acute care health services in non-urban communities. Health Management Associates Inc., has a market cap of $1.59 billion; its shares were traded at around $6.26 with a P/E ratio of 8.2 and P/S ratio of 0.3. Health Management Associates Inc. had an annual average earnings growth of 27.7% over the past 10 years. GuruFocus rated Health Management Associates Inc. the business predictability rank of 4-star.
On October 24, Health Management Associates Inc. announced its consolidated financial results for the third quarter ended September 30, 2011.Revenue increased 12.0% to $1,400.2 million; income from continuing operations increased 24.2% to $49.7 million. Adjusted EBITDA increased 14.9% to $195.5 million. Adjusted EBITDA excludes approximately $9.3 million, or $0.02 per diluted share, of acquisition and government investigation related expenses.
Last week, Executive Vice President of Operations Finance Kerrin E. Gillespie bought 25,000 shares of HMA stock. Vice President and Treasurer Joseph C. Meek and Executive Vice President and CFO Kelly E. Curry bought shares in August.
Commercial Metals Co. (CMC): Director Rhys J Best Bought 5,000 Shares
Director of Commercial Metals Co. Rhys J. Best, bought 5,000 shares on 1/12/2012 at an average price of $12.66. Commercial Metals Company has three segments: manufacturing, recycling, and marketing and trading. Commercial Metals Co. has a market cap of $1.46 billion; its shares were traded at around $12.66 with a P/E ratio of 43.6 and P/S ratio of 0.2. The dividend yield of Commercial Metals Co. stocks is 3.8%.
On January 6, Commercial Metals Company reported net earnings of $107.7 million or $0.93 per diluted share on net sales of $2.0 billion for the first quarter ended November 30, 2011. Net earnings from continuing operations increased significantly to $125.0 million or $1.07 per diluted share as compared to net earnings of $14.9 million or $0.13 per diluted share for last year's first quarter.
This month, Director Rick J. Mills, Director Rhys J. Best, Senior Vice President and General Counsel and Corporate Secretary Ann J. Bruder, and Senior Vice President CFO Barbara Smith bought shares of CMC stock. Director Sarah E. Raiss and President and CEO Joseph Alvarado bought shares in November.
For the complete list of stocks that bought by their company executives, go to: Insider Buys.